The Health Policy Partnership

EU Legislative Interests

Public health and healthcare policy, specific focus in cancer, heart failure, and health data/ technology.

Communication Activities

HEART FAILURE POLICY NETWORK (HFPN) HPP acts as Secretariat for HFPN, a multidisciplinary group of experts from across Europe working with patients, health professionals and other stakeholders to lead significant policy changes that may improve the lives of people with heart failure (HF). The HFPN has ongoing and new relationships with several MEPs who donate their time for free to support (and act as Members of) the HFPN. In 2023, HFPN initiated the European Heart Failure Mission which aimed to secure political recognition and investment for HF from the EU. Across 2025, activites completed as part of the mission have included the following: * HFPN has made submissions of evidence to support the development of the EU Cardiovascular Health Plan during the consultation period. This submission included recommendations for how HF should be included in the plan. The submission has been widely shared online * HFPN has shared evidence, the submission above and other documentation, directly with MEPs and otherwise spoken to MEPs to support the development of the INI report on an EU cardiovascular diseases strategy. * HFPN has been in contact with Oliver Varhelyi, Commissioner for health and animal welfare with submissions of evidence and a petition signed by HFPN membership, as well as other members of the commission. * Discussions of how HF can be adequately represented in EU policy were furthered in a dedicated policy event in Brussels in November 2024. The event was hosted by MEP Romana Jerkovic. Funding for the HFPN is provided by AstraZeneca, Bayer and Roche DIagnostics. The EU Mission activities are funded by AstraZeneca and Roche Diagnostics. HFPN has subcontracted with, and been supported in outreach and logistics by Acumen Public Affairs Ltd (EU Transparency Register ID: 85679286747-21). LUNG CANCER POLICY NETWORK (LCPN) HPP acts as Secretariat for the LCPN. The network was established in 2021. It is an international, multidisciplinary alliance of stakeholders who are dedicated to making lung cancer a policy priority worldwide and driving meaningful change for people with the disease. The network's membership includes patient, industry and screening programme representatives; lung cancer coalitions; professional associations; public health and screening experts; and thought leaders on early detection & lung cancer epidemiology. Relevant activities, covered under the Register are noted as follows: * LCPN delivered a side-event at the European Lung Cancer Congress in March 2025, with Penilla Gunther, a member of the EU Cancer Mission Board, delivering a presentation on ‘The importance of implementing lung cancer screening across Europe’ & participating in a panel discussion with other stakeholders. * LCPN participated in an event organised by the SOLACE consortium in November 2025 focused on the future of lung cancer screening across Europe. MEP Nikos Papandreou and Dr Ciaran Nicholl from the European Commission’s Joint Research Centre were in attendance. * While the LCPN has not called upon EU institutions specifically to make policy changes, the network has referenced EU institutions and the European Beating Cancer Plan in several published materials. This includes the ‘Practical considerations and next steps for advancing lung cancer screening implementation in Central & Eastern Europe’ report, published in October 2025. Funding for the LCPN is provided by Amgen, AstraZeneca, Bristol Myers Squibb Foundation, Johnson & Johnson, MSD, Pfizer, Siemens Healthineers, Guardant Health & GE HealthCare. Lilly also provides funding to the Network on an arm's-length basis, having no control or influence over the Network or activities. OUR HEALTH IN THE CLOUD. We published a report, funded by Amazon Europe Core SARL, working with the European Institute for Innovation through Health Data, focusing on the challenges of health data & the relevance of cloud technology as a key enabler of a comprehensive approach to managing data.

Interests Represented

Promotes their own interests or the collective interests of their members

Member Of

Heart Failure Policy Network - www.hfpolicynetwork.eu (provide secretariat and lead project)

Organisation Members

Please see www.hfpolicynetwork.eu

Additional Information

Specific financial references to: Amazon Europe Core SARL [Our health in the cloud] €15,442